Adverse Events and Oncotargeted Kinase Inhibitors - Image 1

£133.29

Academic Press Adverse Events and Oncotargeted Kinase Inhibitors

Name: Adverse Events and Oncotargeted Kinase Inhibitors
Brand: Academic Press
Price: 133.29 GBP
Availability: InStock

Pharmacy - Dispensing

About as cheap as it gets. The only time it was cheaper was 7 months ago.

£133 today · all-time low £128 (Oct 2025) · usually the usual

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey

↓ Forecast
where the price is heading next

↓ Statistics
all-time high & low, recent range

↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 625 days • 625 data points (No recent data available)

Historical

Generating forecast...

Price Distribution

Price distribution over 625 days • 9 price levels

Days at Price

Current Price

Price Analysis

Most common price: £131 (209 days, 33.4%)

Price range: £129 - £145

Price levels: 9 different prices over 625 days

Description

Adverse Events and Oncotargeted Kinase Inhibitors gathers and evaluates data on adverse events associated with tyrosine kinase inhibitors (TKIs), a powerful anti-tumor drug class that has recently been introduced for human therapy. This book compiles a comprehensive safety profile of each TKI from experiences in official therapeutic indications, also exploring off-label exploratory investigations and postmarketing pharmaceutical surveillance databases. A brief history of each drug’s development and submission is provided, along with a more detailed analysis of the mechanism(s) of action involved in therapeutic activity or related to the insurgence of specific adverse events. Early chapters focus on general characteristics of TKIs, typology, and classification of adverse events, while the final chapters analyze TKIs as AE inducers and classes of AEs by system or organ involvement. This comprehensive resource compiles and critically reviews all of the relevant safety data for this class of drugs, with the goal of improving the understanding of pathogenesis and facilitating the prevention, monitoring, and management of these adverse events. Offers a unique and comprehensive publication on the adverse events associated with a new and fast-growing class of medicines Provides a systematic analysis of adverse events aimed at better prevention through understanding and offering insights for the development of safer drugs Uses practical guidelines to establish a leading reference on this class of drugs for educators, researchers, drug developers, clinicians, safety professionals, and more

Product Specifications

Brand: Academic Press
Format: hardcover
ASIN: 0128094001
Category: Books > Subjects > Health, Family & Lifestyle > Medical & Healthcare Practitioners > Allied Health Professions > Pharmacy - Dispensing
Domain: Amazon UK
Release Date: 12 May 2017
Listed Since: 30 September 2016

Barcode

No barcode data available

Academic Press Adverse Events and Oncotargeted Kinase Inhibitors

About as cheap as it gets. The only time it was cheaper was 7 months ago.

Price History & Forecast

Price Distribution

Price Analysis

Description

Product Specifications

Barcode

Similar Products You Might Like

CRC Press - Chemistry and Pharmacology of Anticancer Drugs

Chemistry and Pharmacology of Anticancer Drugs

Protein Kinase Inhibitors as Sensitizing Agents for Chemotherapy (Volume 4)

Molecules Engineered Against Oncogenic Proteins and Cancer: Discovery, Design, and Development

Small Molecules for Cancer Treatment

Phase I Oncology Drug Development

Handbook of Anticancer Pharmacokinetics and Pharmacodynamics (Cancer Drug Discovery and Development)

Handbook of Anticancer Pharmacokinetics and Pharmacodynamics (Cancer Drug Discovery and Development)

Pharmacokinetics in Drug Development: Problems and Challenges in Oncology, Volume 4

Academic Press pH-Interfering Agents in Cancer Therapy Vol 10

Medicines for Cancer: Mechanism of Action and Clinical Pharmacology of Chemo, Hormonal, Targeted, and Immunotherapies

Pharmacokinetics in Drug Development: Problems and Challenges in Oncology, Volume 4

Novel Designs of Early Phase Trials for Cancer Therapeutics

Medicinal Chemistry of Chemotherapeutic Agents: A Comprehensive Resource of Anti-infective and Anti-cancer Drugs

Handbook of Cancer Treatment-Related Symptoms and Toxicities

Cancer Therapeutics: Experimental and Clinical Agents (Cancer Drug Discovery and Development)

Small Molecules in Oncology: 201 (Recent Results in Cancer Research)

Combination Cancer Therapy: Modulators and Potentiators (Cancer Drug Discovery and Development)

Cancer Chemotherapy: Basic Science to the Clinic

Cytotoxic Anticancer Drugs: Models and Concepts for Drug Discovery and Development: Proceedings of the Twenty-Second Annual Cancer Symposium Detroit, ... 1990: 68 (Developments in Oncology, 68)

Protein Tyrosine Kinases: From Inhibitors to Useful Drugs (Cancer Drug Discovery and Development)

Animal Models in Cancer Drug Discovery

Medicinal Chemistry of Anticancer Drugs

Wiley Anticancer Therapeutics - Oncology Drug Design Book